Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Shenzhen Kangtai Biological Products Co., Ltd.
  6. News
  7. Summary
    300601   CNE100002Q33

SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.

(300601)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021

04/29/2021 | 04:29am EST

Shenzhen Kangtai Biological Products Co., Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 276.993 million compared to CNY 177.202 million a year ago. Operating income was CNY 29.614 million compared to CNY 5.147 million a year ago. Net income was CNY 25.152 million compared to CNY 2.424 million a year ago. Basic earnings per share from continuing operations was CNY 0.0369 compared to CNY 0.0038 a year ago. Diluted earnings per share from continuing operations was CNY 0.0364 compared to CNY 0.0037 a year ago.


ę S&P Capital IQ 2021
All news about SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.
11/19Shenzhen Kangtai Biological Products Co., Ltd. Announces Export of Kangtai Adenovirus V..
CI
11/19AstraZeneca's Chinese Distributor Sends First Vaccine Shipment To Indonesia
MT
11/19China's BioKangtai begins first shipment of AstraZeneca's COVID-19 shot
RE
11/03National Agency of Drug and Food Control Grants the Emergency Use Authorization for Cov..
CI
10/21Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Nine Mo..
CI
09/24Shenzhen Kangtai Biological Products Co., Ltd. Announces 2021 Interim Distribution Plan..
CI
09/16Shenzhen Kangtai Biological Products Co., Ltd. Approves Interim Cash Dividend for the F..
CI
09/08Shenzhen Kangtai Biological Products Co., Ltd. Announces Recombinant COVID-19 Vaccine (..
CI
08/30Shenzhen Kangtai Biological Products Co., Ltd. Proposes Cash Dividend for the First Hal..
CI
08/29Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Half Ye..
CI
More news
Financials
Sales 2021 3 756 M 588 M 588 M
Net income 2021 1 164 M 182 M 182 M
Net cash 2021 3 514 M 550 M 550 M
P/E ratio 2021 67,7x
Yield 2021 0,20%
Capitalization 78 184 M 12 232 M 12 231 M
EV / Sales 2021 19,9x
EV / Sales 2022 13,3x
Nbr of Employees 2 043
Free-Float 46,4%
Chart SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.
Duration : Period :
Shenzhen Kangtai Biological Products Co., Ltd. Technical Analysis Chart | 300601 | CNE100002Q33 | MarketScreener
Technical analysis trends SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 113,80 CNY
Average target price 177,75 CNY
Spread / Average Target 56,2%
EPS Revisions
Managers and Directors
Wei Min Du Chairman & General Manager
Xiang Miao Chief Financial Officer & Board Secretary
Zhi Yun Lu Chairman-Supervisory Board
Xiang Ming Li Independent Director
Dong Guang Ma Independent Director
Sector and Competitors